Bortezomib Plus Rituximab for EBV+ PTLD

Clinical trial NCT01058239 · COMPLETED

Trial details

NCT number: NCT01058239
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post-transplant Lymphoproliferative Disease Solid Organ Transplant Stem Cell Transplant (Bone Marrow Transplant)Epstein Barr Virus Infections

Start date: 2011-11-01
Primary completion: 2016-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.